rs ID | A1a | All sub-group participants (127 cases vs 1268 controls) | Well controlled glucose (23 cases vs 657 controls) | Uncontrolled glucose (104 cases vs 611 controls) | |||
---|---|---|---|---|---|---|---|
ORb [95% CIc] | P | OR [95% CI] | P | OR [95% CI] | P | ||
rs6818140 | G | 2.773 [0.636–12.085] | 0.174 | 11.773 [0.832–166.650] | 0.068 | 1.610 [0.336–7.722] | 0.552 |
rs7688743 | A | 0.241 [0.058–1.005] | 0.051 | 0.049 [0.004–0.672] | 0.024 | 0.425 [0.092–1.954] | 0.272 |
rs10011540 | G | 2.612 [0.592–11.528] | 0.205 | 18.758 [1.006–349.653] | 0.050 | 1.448 [0.304–6.907] | 0.642 |
rs3811787 | T | 0.490 [0.293–0.822] | 0.007 | 0.505 [0.158–1.617] | 0.250 | 0.467 [0.251–0.871] | 0.017 |
rs3811790 | A | 1.111 [0.687–1.798] | 0.667 | 1.919 [0.612–6.015] | 0.264 | 1.125 [0.643–1.970] | 0.679 |
rs3811791 | C | 0.689 [0.385–1.234] | 0.211 | 0.704 [0.187–2.644] | 0.603 | 0.608 [0.299–1.238] | 0.170 |
rs1472268 | A | 0.906 [0.005–166.826] | 0.970 | 0.001 [< 0.01- > 999] | 0.982 | > 999 [< 0.01- > 999] | 0.959 |
rs1800592 | T | 1.282 [0.007–236.211] | 0.926 | > 999 [< 0.01- > 999] | 0.981 | < 0.01 [< 0.01- > 999] | 0.959 |
rs659366 | T | 2.790 [0.533–14.599] | 0.224 | 0.506 [0.066–3.899] | 0.513 | 5.665 [0.812–39.498] | 0.080 |
rs591758 | C | 0.222 [0.040–1.237] | 0.086 | 1.244 [0.125–12.341] | 0.852 | 0.103 [0.014–0.762] | 0.026 |
rs1685356 | T | 1.004 [0.699–1.443] | 0.981 | 0.592 [0.262–1.340] | 0.209 | 1.203 [0.793–1.826] | 0.384 |
rs3741135 | A | 1.565 [0.838–2.924] | 0.160 | 1.182 [0.343–4.068] | 0.791 | 1.770 [0.819–3.825] | 0.146 |
rs2734827 | A | 0.881 [0.481–1.615] | 0.683 | 0.381 [0.050–2.922] | 0.354 | 1.217 [0.618–2.399] | 0.570 |